In addition, Corrado C et al. found that when the expression of H19 was silenced in multiple myeloma (MM) cell lines, the transcription level of HIF-1α and the expression levels of its downstream target genes VEGF and SNAIL were reduced, suggesting that H19 is a HIF-1α activator. This evidence concerns the gene HIF1A and Miyoshi myopathy.